These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 10585815

  • 1. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D, Climo MW, Wong AH, Edmond MB, Wenzel RP.
    Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z, Cao B, Liu YM, Gu L, Wang C.
    Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR.
    J Antimicrob Chemother; 2009 Dec 05; 64(6):1226-9. PubMed ID: 19833635
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC.
    Int J Antimicrob Agents; 2007 Nov 05; 30(5):398-408. PubMed ID: 17888634
    [Abstract] [Full Text] [Related]

  • 6. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM, Boyle-Vavra S, Shete PB, Daum RS.
    J Infect Dis; 2002 Sep 01; 186(5):661-7. PubMed ID: 12195353
    [Abstract] [Full Text] [Related]

  • 7. Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients.
    Ray AJ, Pultz NJ, Bhalla A, Aron DC, Donskey CJ.
    Clin Infect Dis; 2003 Oct 01; 37(7):875-81. PubMed ID: 13130397
    [Abstract] [Full Text] [Related]

  • 8. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G, White R, Friedrich L.
    J Antimicrob Chemother; 2007 Oct 01; 60(4):788-94. PubMed ID: 17623693
    [Abstract] [Full Text] [Related]

  • 9. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI, García-Cañas A, García-Hierro P, Rodríguez-Salvanés F.
    J Antimicrob Chemother; 2008 Oct 01; 62(4):773-5. PubMed ID: 18552338
    [Abstract] [Full Text] [Related]

  • 10. Elevated vancomycin minimum inhibitory concentrations among methicillin-resistant Staphylococcus aureus isolated from patients with ventilator-associated pneumonia at a Connecticut hospital.
    Kuti JL, Nicasio AM, Sutherland CA, Nicolau DP.
    Conn Med; 2009 Oct 01; 73(6):337-40. PubMed ID: 19637663
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, Dukart G, Babinchak T, Cooper CA, Ellis-Grosse EJ, Dartois N, Gandjini H, 307 Study Group.
    J Antimicrob Chemother; 2008 Sep 01; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [Abstract] [Full Text] [Related]

  • 12. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S.
    Mikrobiyol Bul; 2007 Oct 01; 41(4):511-6. PubMed ID: 18173069
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD, Citron DM.
    Diagn Microbiol Infect Dis; 2010 Apr 01; 66(4):441-4. PubMed ID: 20226335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT, Li Y, Wang J, China Bacterial Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):365-74. PubMed ID: 12820911
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug 10; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 19. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.
    Chung G, Cha J, Han S, Jang H, Lee K, Yoo J, Yoo J, Kim H, Eun S, Kim B, Park O, Lee Ys.
    J Microbiol Biotechnol; 2010 Mar 10; 20(3):637-42. PubMed ID: 20372039
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.